Les dernières avancées de GERCA

Retrouvez nos dernières actualités sur la recherche, nos collaborations internationales, et nos initiatives en cardiologie.

À la une

portrait of doctor
samedi 28 décembre 2024
Testimonial: From Research to International Recognition
Supported by GERCA, Walaa Fakih completed her PhD on atrial fibrillation in Strasbourg, achieved significant advancements, and presented her findings at international scientific conferences.
Walaa Fakih
picture of thesis presentation
mardi 17 décembre 2024
Testimonial: GERCA Supports Thesis on Aortic Stenosis
A study at Strasbourg University Hospital has unveiled new insights into aortic stenosis mechanisms, identifying potential therapeutic targets for France's most common heart valve disease. This research, made possible through GERCA's support, could pave the way for medical treatments that might help patients avoid surgical intervention.
Antonin Trimaille
portrait of doctor
vendredi 6 décembre 2024
Testimonial: a Vietnamese-French Collaboration
A Vietnamese researcher, supported by GERCA, is advancing critical research on rheumatic mitral valve stenosis—a condition causing 1.4 million deaths annually. With GERCA’s funding, their study explores innovative therapies like Empagliflozin, bridging collaboration between Vietnam and France to tackle health inequities in underserved regions.
Trung Anh Mai
lundi 30 décembre 2024
Benjamin Marchandot

GERCA: A Hub of Collaboration and Innovation

As a cardiologist with GERCA, I have witnessed the inspiring diversity and collaboration within the Translational Cardiovascular Medicine research unit. Supported by GERCA, this unique ecosystem brings together global talents to advance groundbreaking projects and foster lifelong connections.

Lire la suite
jeudi 12 décembre 2024
GERCA

Testimonial: a Chinese-French collaboration enabled by GERCA

GERCA’s support enabled research on septic cardiovascular dysfunction, a life-threatening condition with high mortality rates. The research, conducted in Strasbourg, investigated the role of SGLT2 and its inhibitor, empagliflozin, in treating the condition. This research not only advances treatment but also fosters collaboration between China and France in medical research.

Lire la suite
mardi 10 décembre 2024
GERCA

Testimonial: a Japanese-French collaboration enabled by GERCA

Kensuke Matsushita, a cardiologist, highlights his research in structural heart disease and COVID-19-related cardiovascular disease. He expresses gratitude for the support he received during his doctoral studies at the University of Strasbourg, emphasizing the importance of preserving opportunities for international scientific exchanges.

Lire la suite